Search Results 221-230 of 17209 for hba1c

1. A Study of the Effectiveness and Safety of Subcutaneous Semaglutide for Patients with Fatty-Liver Disease, not Caused by Alcoholism - Mayo Clinic

   HbA1c above 9% at screening; History or presence of pancreatitis (acute or chronic); Calcitonin equal or above 50 ng/L at screening; Family or personal history ...

2. A Study To Test Whether Survodutide Helps People With A Liver disease Called NASH/MASH Who Have Moderate Or Advanced liver Fibrosis - Mayo Clinic

   HbA1c > 10% (> 86 mmol/mol) as measured by the central laboratory at screening. Impaired renal function, defined as eGFR 2x ULN as measured by the central ...

3. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

4. Publications - Nikola A. Baumann, Ph.D. - Mayo Clinic

   Assessing Quality Control Strategies for HbA1c Measurements From a Patient Risk Perspective. J Diabetes Sci Technol. 2018 Jul; 12 (4):786-791 Epub 2018 Feb ...

5. Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes - Mayo Clinic

   HbA1c < 9.0% in the last 6 months. If not available must be performed for study qualification. Willing to implement and adhere to pump alert/alarm settings ...

6. A Study To Evaluate Bardoxolone Methyl In Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

   Uncontrolled diabetes (HbA1c > 11.0%) at Screen A visit. Serum albumin < 3 g/dL at Screen A visit. History of intracranial aneurysms. Kidney or any other ...

7. New treatment option for early type 1 diabetes - Mayo Clinic

   According to a recent study, a new immune-modulating therapy helps slow the rate of islet cell loss for people in the early stages of type 1 diabetes.

8. CraniSeal Post Approval Study - Clinical Trials

   ... HbA1c elevation of \>9% despite standard diabetes care), * Patient has a documented, uncorrectable clinically significant coagulopathy (e.g., PTT\>37 ...

9. Safety Study Of OA-235i In Subjects With Nonalcoholic Steatohepatitis - Mayo Clinic

   Uncontrolled diabetes, defined as HbA1c of ≥ 9.5% within 60 days prior to Screening. History or presence of a compromised immune system including inherited ...

10. Sitagliptin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Sitagliptin and metformin combination is used together with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. Sitagliptin ...